Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison

Authors: David Cherney, Kerstin Folkerts, Paul Mernagh, Mateusz Nikodem, Joerg Pawlitschko, Peter Rossing, Neil Hawkins

Source: Journal of Market Access & Health Policy, Vol 12, Iss 3, Pp 169-180 (2024)

Subject Terms: chronic kidney disease (CKD), type 2 diabetes (T2D), finerenone, canagliflozin, sodium glucose cotransporter 2 inhibitors (SGLT2i), matching-adjusted indirect comparison (MAIC), Public aspects of medicine, RA1-1270, Business, HF5001-6182

File Description: electronic resource

Relation: https://www.mdpi.com/2001-6689/12/3/14; https://doaj.org/toc/2001-6689

Access URL: https://doaj.org/article/dff937541dc9404db1fe3b6590a96398

SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice

Authors: Nerea Martos-Guillami, Ander Vergara, Carmen Llorens-Cebrià, Aku Enam Motto, Irene Martínez-Díaz, Francisco Gonçalves, Maria Magdalena Garcias-Ramis, Estibaliz Allo-Urzainqui, Alonso Narváez, Sheila Bermejo, Vicent Muñoz, Juan León-Román, Roser Ferrer-Costa, Conxita Jacobs-Cachá, Jordi Vilardell-Vilà, María José Soler

Source: Frontiers in Pharmacology, Vol 15 (2024)

Subject Terms: diabetes, chronic kidney disease (CKD), diabetic kidney disease (DKD), sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like-1 receptor agonists (GLP-1RA), renin-angiotensin system (RAS), Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1415879/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/7e319ae57f3040b09b2c9a304b365834

The Promising Potency of Sodium–Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients

Authors: Yibin Zhang, Xiaobin Liao, Jialu Xu, Jiaxin Yin, Shan Li, Mengni Li, Xiaoli Shi, Shujun Zhang, Chunyu Li, Weijie Xu, Xuefeng Yu, Yan Yang

Source: Biomedicines, Vol 12, Iss 12, p 2783 (2024)

Subject Terms: type 2 diabetes mellitus (T2DM), cognitive impairment (CI), sodium–glucose cotransporter 2 inhibitors (SGLT2i), mechanisms and pathways, clinical evidence, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2227-9059/12/12/2783; https://doaj.org/toc/2227-9059

Access URL: https://doaj.org/article/e02a37b55b1544528d36e1539a70de75

SGLT2i: Therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

Authors: Jiajia Wu, Hong Cai, Jia Xia, Tianyi Zhang, Jiayi Yan, Xinhua Shao, Amanda Ying Wang, Jianxiao Shen, Shan Mou

Source: Pharmacological Research, Vol 195, Iss , Pp 106883- (2023)

Subject Terms: Sodium-glucose cotransporter 2 inhibitors (SGLT2i), Contrast induced acute kidney injury (CI-AKI), Non-diabetes, Predisposing factors, Treatment measures, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1043661823002396; https://doaj.org/toc/1096-1186

Access URL: https://doaj.org/article/e6133551728b4a4681131bd4ed32ec56

Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report

Authors: Brian Vadasz, Mattan Arazi, Yousef Shukha, Ofir Koren, Riad Taher

Source: Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-5 (2021)

Subject Terms: Diabetic ketoacidosis, Sodium-glucose cotransporter 2 inhibitors (SGLT2i), Latent autoimmune diabetes in adults (LADA), Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1752-1947

Access URL: https://doaj.org/article/48a3daf221024752bc36f753432098c4

SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study

Authors: Tongtong Wang, Shrita M. Patel, Anne Hickman, Xinyue Liu, Philip LStJ Jones, Ira Gantz, Carol E. Koro

Source: Diabetes Therapy, Vol 11, Iss 3, Pp 711-723 (2020)

Subject Terms: Antihyperglycemic agents, Fournier’s gangrene, Nested case–control study, Sodium–glucose cotransporter 2 inhibitors (SGLT2i), Type 2 diabetes, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: https://doaj.org/toc/1869-6961

Access URL: https://doaj.org/article/57a78bad45474da09e6cb960c8bf56c0

Euglycemic diabetic ketoacidosis caused by canagliflozin: a case report

Authors: Masafumi Fukuda, Masakazu Nabeta, Takanori Muta, Kei Fukami, Osamu Takasu

Source: International Journal of Emergency Medicine, Vol 13, Iss 1, Pp 1-4 (2020)

Subject Terms: Canagliflozin, Sodium glucose cotransporter 2 inhibitors (SGLT2i), Euglycemic diabetic ketoacidosis (eu-DKA), Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9

File Description: electronic resource

Relation: https://doaj.org/toc/1865-1372; https://doaj.org/toc/1865-1380

Access URL: https://doaj.org/article/7e8e677e332d43e0983a6510902a7208

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.